116 related articles for article (PubMed ID: 34902437)
1. Pancreastatin inhibitor PSTi8 prevents free fatty acid-induced oxidative stress and insulin resistance by modulating JNK pathway: In vitro and in vivo findings.
Garg R; Gupta AP; Katekar R; Verma S; Goand UK; Dadge S; Gayen JR
Life Sci; 2022 Jan; 289():120221. PubMed ID: 34902437
[TBL] [Abstract][Full Text] [Related]
2. Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice.
Gupta AP; Singh P; Garg R; Valicherla GR; Riyazuddin M; Syed AA; Hossain Z; Gayen JR
Biomed Pharmacother; 2019 Aug; 116():108959. PubMed ID: 31108350
[TBL] [Abstract][Full Text] [Related]
3. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway.
Gupta AP; Syed AA; Garg R; Goand UK; Singh P; Riyazuddin M; Valicherla GR; Husain A; Gayen JR
Eur J Pharmacol; 2019 Dec; 864():172723. PubMed ID: 31586632
[TBL] [Abstract][Full Text] [Related]
4. The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways.
Gao D; Nong S; Huang X; Lu Y; Zhao H; Lin Y; Man Y; Wang S; Yang J; Li J
J Biol Chem; 2010 Sep; 285(39):29965-73. PubMed ID: 20647313
[TBL] [Abstract][Full Text] [Related]
5. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
[TBL] [Abstract][Full Text] [Related]
6. Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus.
Hossain Z; Valicherla GR; Gupta AP; Syed AA; Riyazuddin M; Chandra S; Siddiqi MI; Gayen JR
Sci Rep; 2018 Jun; 8(1):8715. PubMed ID: 29880906
[TBL] [Abstract][Full Text] [Related]
7. Pancreastatin inhibitor PSTi8 ameliorates insulin resistance by decreasing fat accumulation and oxidative stress in high-fat diet-fed mice.
Garg R; Agarwal A; Katekar R; Goand UK; Singh N; Yadav S; Rathaur S; Verma S; Maity D; Vishwakarma S; Gayen JR
Amino Acids; 2023 Nov; 55(11):1587-1600. PubMed ID: 37716928
[TBL] [Abstract][Full Text] [Related]
8. Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT/GSK-3β and PKCλ/ζ/SREBP1c pathways in high fat diet induced insulin resistance in peri-/post-menopausal rats.
Valicherla GR; Gupta AP; Hossain Z; Riyazuddin M; Syed AA; Husain A; Lahiri S; Dave KM; Gayen JR
Peptides; 2019 Oct; 120():170147. PubMed ID: 31473204
[TBL] [Abstract][Full Text] [Related]
9. Combination of Pancreastatin inhibitor PSTi8 with metformin inhibits Fetuin-A in type 2 diabetic mice.
Singh P; Garg R; Goand UK; Riyazuddin M; Reza MI; Syed AA; Gupta AP; Husain A; Gayen JR
Heliyon; 2020 Oct; 6(10):e05133. PubMed ID: 33033766
[TBL] [Abstract][Full Text] [Related]
10. Pancreastatin inhibitor PSTi8 ameliorates streptozotocin-induced diabetes by suppressing hepatic glucose production.
Garg R; Katekar R; Parwez S; Agarwal A; Sahu S; Dadge S; Verma S; Goand UK; Siddiqi MI; Gayen JR
Eur J Pharmacol; 2023 Apr; 944():175559. PubMed ID: 36764353
[TBL] [Abstract][Full Text] [Related]
11. Immuno-metabolic effect of pancreastatin inhibitor PSTi8 in diet induced obese mice: In vitro and in vivo findings.
Goand UK; Verma S; Patel I; Tasneem S; Garg R; Gayen JR
Life Sci; 2023 Mar; 316():121415. PubMed ID: 36690247
[TBL] [Abstract][Full Text] [Related]
12. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria.
Nakamura S; Takamura T; Matsuzawa-Nagata N; Takayama H; Misu H; Noda H; Nabemoto S; Kurita S; Ota T; Ando H; Miyamoto K; Kaneko S
J Biol Chem; 2009 May; 284(22):14809-18. PubMed ID: 19332540
[TBL] [Abstract][Full Text] [Related]
13. PINK1 alleviates palmitate induced insulin resistance in HepG2 cells by suppressing ROS mediated MAPK pathways.
Cang X; Wang X; Liu P; Wu X; Yan J; Chen J; Wu G; Jin Y; Xu F; Su J; Wan C; Wang X
Biochem Biophys Res Commun; 2016 Sep; 478(1):431-438. PubMed ID: 27423393
[TBL] [Abstract][Full Text] [Related]
14. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
[TBL] [Abstract][Full Text] [Related]
15. Pancreastatin inhibitor PSTi8 balances energy homeostasis by attenuating adipose tissue inflammation in high fat diet fed mice.
Goand UK; Verma S; Gupta AP; Garg R; Dadge S; Gayen JR
Peptides; 2023 Jan; 159():170902. PubMed ID: 36375661
[TBL] [Abstract][Full Text] [Related]
16. FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress.
Pereira S; Park E; Mori Y; Haber CA; Han P; Uchida T; Stavar L; Oprescu AI; Koulajian K; Ivovic A; Yu Z; Li D; Bowman TA; Dewald J; El-Benna J; Brindley DN; Gutierrez-Juarez R; Lam TK; Najjar SM; McKay RA; Bhanot S; Fantus IG; Giacca A
Am J Physiol Endocrinol Metab; 2014 Jul; 307(1):E34-46. PubMed ID: 24824652
[TBL] [Abstract][Full Text] [Related]
17. CtBP2 ameliorates palmitate-induced insulin resistance in HepG2 cells through ROS mediated JNK pathway.
Liu P; Shi L; Cang X; Huang J; Wu X; Yan J; Chen L; Cui S; Ye X
Gen Comp Endocrinol; 2017 Jun; 247():66-73. PubMed ID: 28111233
[TBL] [Abstract][Full Text] [Related]
18. Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning.
Reza MI; Syed AA; Singh P; Husain A; Gayen JR
Life Sci; 2021 Nov; 284():119905. PubMed ID: 34453940
[TBL] [Abstract][Full Text] [Related]
19. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes.
Nguyen MT; Satoh H; Favelyukis S; Babendure JL; Imamura T; Sbodio JI; Zalevsky J; Dahiyat BI; Chi NW; Olefsky JM
J Biol Chem; 2005 Oct; 280(42):35361-71. PubMed ID: 16085647
[TBL] [Abstract][Full Text] [Related]
20. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression.
Hwang HJ; Jung TW; Kim BH; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
Biochem Pharmacol; 2015 Nov; 98(1):157-66. PubMed ID: 26297911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
